RPWA
TXG icon

Regent Peak Wealth Advisors’s 10x Genomics TXG Stock Holding History

Regent Peak Wealth Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323K Buy
+8,421
New +$221K 0.06% 141
2021
Q1 		– Sell
-18
Closed -$3K – 920
2020
Q4 		$3K Buy
+18
New +$2.61K ﹤0.01% 778

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Regent Peak Wealth Advisors's TXG Position: Q2 2026 in Review

Regent Peak Wealth Advisors opened a new position in 10x Genomics (TXG) in Q2 2026: 8,421 shares worth $323K. The stake represents 0.06% of the portfolio and ranks #141 among its holdings. This is a return to the name: Regent Peak Wealth Advisors previously reported a position in TXG as recently as Q4 2020.

Regent Peak Wealth Advisors first reported a position in TXG in Q4 2020 and has held it in 2 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Regent Peak Wealth Advisors held 8,421 shares of 10x Genomics worth $323K as of Q2 2026.
  • 10x Genomics was a new Regent Peak Wealth Advisors position in Q2 2026.
  • 10x Genomics made up 0.06% of Regent Peak Wealth Advisors's portfolio in Q2 2026, its #141 holding.
  • Regent Peak Wealth Advisors first reported a position in 10x Genomics in Q4 2020 and has held it in 2 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Regent Peak Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.